Analystreport

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had its price target raised by analysts at BTIG Research from $60.00 to $63.00. They now have a "buy" rating on

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com